Connect with us

Business

Prescription For Growth: Pharma, Health Sectors Seek R&D Boost, Higher Spending From Budget 2026

Published

on

Prescription For Growth: Pharma, Health Sectors Seek R&D Boost, Higher Spending From Budget 2026


Last Updated:

Industry leaders say Budget 2026 is a crucial moment to shift from a volume-driven healthcare economy to one anchored in innovation, prevention and long-term resilience

Calling for higher public health spending, the corporate honchos & healthcare lobbies have asked for targeted tax incentives for research and manufacturing, regulatory reforms to support innovation and affordability. Representational image

Calling for higher public health spending, the corporate honchos & healthcare lobbies have asked for targeted tax incentives for research and manufacturing, regulatory reforms to support innovation and affordability. Representational image

India’s pharmaceutical and healthcare sectors have pitched for a strong policy push in the Union Budget to raise health spending, revive R&D incentives and reform regulations to strengthen global competitiveness.

Calling for higher public health spending, the corporate honchos & healthcare lobbies have asked for targeted tax incentives for research and manufacturing, regulatory reforms to support innovation and affordability.

Industry leaders told News18 that while India has emerged as a global supplier of affordable medicines and medical devices, mounting pressures from geopolitical uncertainty, tariff barriers, supply-chain disruptions and rising non-communicable diseases (NCDs) require sustained fiscal and policy support.

The coming Budget on Sunday, they argue, is a crucial moment to shift from a volume-driven healthcare economy to one anchored in innovation, prevention and long-term resilience.

At the core of the demands are calls to revive incentives for pharmaceutical research and development, address tax and GST anomalies affecting manufacturing, strengthen domestic MedTech production, and expand public healthcare financing in line with national health targets. Healthcare providers, meanwhile, are seeking reforms in insurance coverage, reimbursements and preventive care as disease patterns shift sharply towards chronic illnesses.

Pharma: R&D push, tax reforms and manufacturing competitiveness

Pharmaceutical companies have urged the government to reinforce India’s innovation ecosystem through globally competitive R&D incentives and a stable policy environment.

According to Sudarshan Jain, secretary general, Indian Pharmaceutical Alliance, the lobby of the domestic pharma companies, including Sun Pharma, Cipla, Glenmark and IPCA Labs, “The industry seeks globally competitive R&D incentives that align with India’s innovation ambitions, enhance the scientific ecosystem, and support the transition from a volume-driven model to an innovation-led pharmaceutical sector.”

The industry is seeking restoration of the weighted R&D tax deduction of up to 200% and a strengthened patent box regime with a competitive 5% tax rate to support innovation in complex generics, biosimilars, vaccines and novel drugs. Companies have also flagged the need to rationalise GST structures to correct inverted duty anomalies that strain manufacturing viability.

Satish Reddy, chairman of pharma giant Dr Reddy’s Laboratories, believes that as the industry undertakes a strategic shift from volume-led expansion to value-driven growth, “closer alignment between science, policy and industry will be critical to advancing innovation across the value chain”. He added that expectations from the budget centre on structured funding frameworks to deepen R&D and enable translation of advanced research into high-value therapies.

“With the sector poised to play a pivotal role in realising the vision of Viksit Bharat and its ambition of becoming a $500 billion industry by 2047, expectations from the Union Budget 2026 centre on the creation of a structured funding framework to deepen innovation and R&D across the country. This would enable the companies to translate advanced research into complex, high-value therapies while improving patient access,” he suggested.

The MedTech industry echoed similar concerns, particularly regarding taxation and domestic capability-building.

“For India to build a truly competitive MedTech manufacturing ecosystem, the sector needs a policy approach that reduces cost disabilities, nurtures local innovation and enables faster market access,” Himanshu Baid, managing director at medtech firm, Poly Medicure. He flagged the inverted GST duty structure, where finished devices attract lower tax rates than inputs, leading to working capital pressures.

Global technology players also emphasised the role of artificial intelligence and exports. Dev Tripathy, head of finance, Philips (Indian Subcontinent), said, “Delivering quality healthcare to the last mile is crucial for India, and this can only be achieved by leveraging AI.”

Tripathy explained that AI will enable “early diagnosis and consolidate data points, helping clinicians make accurate decisions and bridge the supply-demand gap”. “India has the talent to drive AI-led innovation, and incentives for AI innovation, job creation, and high-end service exports through global capability centres (GCCs) must be prioritised,” he said.

Health: NCD burden, insurance gaps and preventive care

On the healthcare delivery side, hospital leaders and diagnostics players highlighted the growing dominance of non-communicable diseases and the need to pivot from episodic treatment to prevention-led care.

Ameera Shah, promoter and executive chairperson at diagnostic lab chain Metropolis Healthcare, said that India stands at a defining moment in its healthcare transition. “With non-communicable diseases projected to account for nearly 75 per cent of morbidity and mortality by 2030 and the economic cost of NCDs estimated at USD 6 trillion over the next decade, the country must urgently pivot from episodic care to comprehensive, holistic care, which is prevention-led, viable and resilient healthcare systems—an essential pillar of the Viksit Bharat vision,” said Shah, president, NATHEALTH, an apex healthcare body serving as a credible and unified voice in improving access and quality of healthcare.

Hospitals have also flagged pressure points in insurance coverage and reimbursements. Dr Purshotam Lal, director-interventional cardiologist and chairman, Metro Group of Hospitals, expects the government to widen Ayushman Bharat–Pradhan Mantri Jan Arogya Yojna (PMJAY). He added that with rising diabetes, hypertension, cardiovascular disease and cancers — especially among younger populations — India needs an insurance model that prioritises preventive healthcare.

Moreover, operational sustainability remains another concern, according to Dr Sanjeev Gupta, medical director, Sri Balaji Action Medical Institute and Action Cancer Hospital, New Delhi, who pointed to delayed reimbursements under government schemes. He said that “timely settlement of dues and clearer pricing frameworks are essential to maintain quality healthcare delivery”, adding that periodic review of package rates was necessary to keep pace with advances such as robotic surgeries and new therapies.

“In an era of rapid innovation, including robotic-assisted surgeries and advanced therapeutics, several government schemes have limited coverage for such procedures, along with capping on certain critical drugs. Periodic review of package rates is therefore essential to keep policies aligned with evolving clinical practices,” said Dr Gupta.

Together, industry leaders argue that Budget 2026 must balance affordability with innovation, strengthen domestic manufacturing, and reorient healthcare delivery towards prevention and early diagnosis — a shift they say is essential to protect both public health and long-term economic growth.

News business Prescription For Growth: Pharma, Health Sectors Seek R&D Boost, Higher Spending From Budget 2026
Disclaimer: Comments reflect users’ views, not News18’s. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.

Read More



Source link

Business

Budget 2026: Fiscal deficit, capex, borrowing and debt roadmap among key numbers to track – The Times of India

Published

on

Budget 2026: Fiscal deficit, capex, borrowing and debt roadmap among key numbers to track – The Times of India


Finance Minister Nirmala Sitharaman is set to present her record ninth straight Union Budget, with markets closely tracking headline numbers ranging from the fiscal deficit and capital expenditure to borrowing and tax revenue projections, as India charts its course as the world’s fastest-growing major economy.The Budget will be presented in a paperless format, continuing the practice of recent years. Sitharaman had, in her maiden Budget in 2019, replaced the traditional leather briefcase with a red cloth–wrapped bahi-khata, marking a symbolic shift in presentation.Here are the key numbers and signals that investors, economists and policymakers will be watching in the Union Budget for 2025-26 and beyond:

Fiscal deficit

The fiscal deficit for the current financial year (FY26) is budgeted at 4.4 per cent of GDP, as reported PTI. With the government having achieved its consolidation goal of keeping the deficit below 4.5 per cent, attention will turn to guidance for FY27. Markets expect the government to indicate a deficit closer to 4 per cent of GDP next year, alongside clarity on the medium-term debt reduction path.

Capital expenditure

Capital spending remains a central pillar of the government’s growth strategy. Capex for FY26 is pegged at Rs 11.2 lakh crore. In the upcoming Budget, the government is expected to continue prioritising infrastructure outlays, with a possible 10–15 per cent increase that could take capex beyond Rs 12 lakh crore, especially as private investment sentiment remains cautious.

Debt roadmap

In her previous Budget speech, the finance minister had said fiscal policy from 2026-27 onwards would aim to keep central government debt on a declining trajectory as a share of GDP. Markets will look for a clearer timeline on when general government debt-to-GDP could move towards the 60 per cent target. General government debt stood at about 85 per cent of GDP in 2024, including central government debt of around 57 per cent.

Borrowing programme

Gross market borrowing for FY26 is estimated at Rs 14.80 lakh crore. The borrowing number announced in the Budget will be closely scrutinised, as it signals the government’s funding needs, fiscal discipline and potential impact on bond yields.

Tax revenue

Gross tax revenue for 2025-26 has been estimated at Rs 42.70 lakh crore, implying an 11 per cent growth over FY25. This includes Rs 25.20 lakh crore from direct taxes—personal income tax and corporate tax—and Rs 17.5 lakh crore from indirect taxes such as customs, excise duty and GST.

GST collections

Goods and Services Tax collections for FY26 are projected to rise 11 per cent to Rs 11.78 lakh crore. Projections for FY27 will be keenly watched, especially as GST revenue growth is expected to gather pace following rate rationalisation measures implemented since September 2025.

Nominal GDP growth

Nominal GDP growth for FY26 was initially estimated at 10.1 per cent but has since been revised down to about 8 per cent due to lower-than-expected inflation, even as real GDP growth is pegged at 7.4 per cent by the National Statistics Office. The FY27 nominal GDP assumption—likely in the 10.5–11 per cent range—will offer clues on the government’s inflation and growth outlook.

Spending priorities

Beyond the headline aggregates, the Budget will also be scanned for allocations to key social and development schemes, as well as spending on priority sectors such as health and education.Together, these numbers will shape expectations on fiscal discipline, growth momentum and policy support as India navigates a complex global economic environment.



Source link

Continue Reading

Business

Budget 2026: Historic 75-year practice to end with major shift in FM’s speech

Published

on

Budget 2026: Historic 75-year practice to end with major shift in FM’s speech


New Delhi: For decades, the Union Budget speech has followed a familiar script. But this year could mark a significant shift. In a departure from a 75-year tradition, Finance Minister Nirmala Sitharaman is expected to use Part B of her Budget speech not just for tax proposals, but to outline a broader and more detailed vision for India’s economic future, according to a report by NDTV which cited sources. 

Understanding Part A and Part B of the Budget

The Union Budget speech is divided into two key sections. Part A outlines the government’s broader policy initiatives and sector-specific strategies aimed at driving growth and development. Part B, on the other hand, deals primarily with taxation proposals, covering both direct and indirect taxes.

Add Zee News as a Preferred Source


Part B May Outline Broader Economic Roadmap

This year, Part B of the Budget speech is expected to go beyond routine tax announcements and present both short-term priorities and long-term goals as India moves deeper into the 21st century, sources said. The focus is likely to highlight India’s domestic strengths while laying out its global ambitions. Economists in India and abroad are closely tracking the developments, expecting a comprehensive roadmap rather than just incremental tax measures.

This will be Nirmala Sitharaman’s ninth consecutive Union Budget presentation. In her first Budget in 2019, she made headlines by replacing the traditional leather briefcase, long used to carry Budget documents with a red cloth-wrapped ‘bahi-khata’, symbolising a break from colonial-era practices. Like the past four years, this year’s Budget will also be presented in a paperless format, continuing the government’s push towards digitisation.

For the current fiscal, capital expenditure has been pegged at Rs 11.2 lakh crore. The government is expected to retain its strong focus on infrastructure and asset creation in the upcoming Budget, with estimates suggesting a 10–15 per cent increase in the capex target, especially as private sector investment continues to remain measured.



Source link

Continue Reading

Business

How new alcohol duty increase is set to affect drink prices in the UK

Published

on

How new alcohol duty increase is set to affect drink prices in the UK


Drinkers across the UK are set to face higher prices for wine and spirits as a significant increase in alcohol duty comes into effect this Sunday, 1 February.

Industry leaders warn that businesses “have no choice but to increase prices” to remain viable amid mounting financial pressures.

The tax levied on alcoholic beverages will rise by 3.66 per cent, in line with the Retail Prices Index (RPI) inflation, a measure confirmed in November’s autumn budget.

While the duty is directly imposed on producers, industry chiefs anticipate a “trickle down” effect, with consumers ultimately bearing the brunt of these additional costs.

Official figures illustrate the impact: the duty on a typical 37.5 per cent alcohol by volume (ABV) bottle of gin will climb by 38p to £8.98, inclusive of VAT.

Similarly, a 40 per cent ABV bottle of Scotch whisky will see its duty increase by 39p, reaching £9.51. A 14.5 per cent red wine will incur an additional 14p in duty.

Rachel Reeves announced an increase in alcohol duty back in November (Getty)

The Wine and Spirit Trade Association (WSTA) highlighted that the duty on a 14.5 per cent red wine has now surged by £1.10 per bottle since the new alcohol duty regime was introduced in August 2023.

In response, the UK Spirits Alliance, representing hundreds of distillers, has urged the Chancellor to use an upcoming duty review to foster growth, address “spirits discrimination,” and establish a long-term strategy for the sector.

The duty structure, partly linked to drink strength, saw an overhaul in 2023, resulting in beer below 3.5 per cent ABV paying significantly less tax.

This has prompted some beer brands, such as Foster’s, to reduce their strength to 3.4 per cent in recent months to mitigate duty costs.

However, the latest increase will affect beer sold in both pubs and supermarkets, marking the first time pubs have been impacted since 2017.

Emma McClarkin, chief executive of the British Beer and Pub Association, stated: “These changes unfortunately increase the likelihood of further price rises, which no brewer or publican would want to inflict on their customers.

“For brewers, who already pay some of the highest rates of beer duty in Europe, this increase will add further strain to their already razor-thin profit margins and risk one of the UK’s world-renowned industries producing the greatest beers in the world.”

Miles Beale, chief executive of the WSTA, criticised the government’s approach: “Despite the OBR (Office for Budget Responsibility) at last acknowledging higher prices lead to a decline in receipts, the Government fails to recognise that its own policy is benefiting no-one.

The increase in alcohol duty has received some criticism (Alamy/PA)

The increase in alcohol duty has received some criticism (Alamy/PA)

“For the nation’s wine and spirit sector the complexities of price changes, especially for wine which is now taxed by strength, mean more red tape headaches ahead.

“Add to this all the other costs – including NI (national insurance) contributions, business rates and waste packaging taxes – and businesses have no choice but to increase prices in order to keep afloat, which unfortunately means consumers are going to take the hit once again.”

Braden Saunders, spokesperson for the UK Spirits Alliance and co-founder of Doghouse Distillery, Battersea, remarked on the timing: “The timing couldn’t be more ironic. Just as dry January draws to a close and people contemplate their first hard-earned drink, they’re met with higher prices at the bar.

“The spirits industry has been treated as a cash cow by consecutive governments, and the sector is on its knees.”

Allen Simpson, chief executive of UKHospitality, echoed these concerns: “Hospitality businesses are facing price pressures at every turn and our sector’s cost burden is growing at an unsustainable rate.

“Increases to alcohol duty, while not paid directly by operators, is another pressure, if it is passed on to businesses through higher drinks prices. We strongly urge suppliers to show restraint in doing so, recognising the economic pressure the sector is under.”

A Treasury spokesman defended the policy, stating: “For too long the economy hasn’t worked for working people, and cost-of-living pressures still bear down. That’s why we are determined to help bring costs down for everyone.

“It’s why we’re taking £150 off energy bills, increasing the National Living Wage, ending the two-child limit, rolling out free breakfast clubs for all primary school children, and freezing fuel duty, rail fares and prescription fees.

“We need to rebuild the public services we all rely on. We’ve put record funding into our schools and NHS to give every child the best start in life and bring down waiting lists.

“Alcohol duty plays an important role in ensuring public finances remain fair and strong and funds the public services people rely on every day.”



Source link

Continue Reading

Trending